Arthur H. Amron - 14 Sep 2026 Form 4 Insider Report for NEPHROS INC (NEPH)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 Sep 2026, 16:59:48 UTC
Prior SEC filing
14 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Arthur H. Amron

Key filing fact

Arthur H. Amron filed Form 4 for NEPHROS INC (NEPH) on 16 Sep 2026.

Key facts

  • This page summarizes Arthur H. Amron's Form 4 filing for NEPHROS INC (NEPH).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 16 Sep 2026, 16:59.

Change

  • Previous filing in this sequence was filed on 14 Aug 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001179697 Primary reporting owner

Amron Arthur H

Relationship
Director
Address
19 CHESTERFIELD ROAD, SCARSDALE
Signature
Arthur H. Amron
Signature date
16 Sep 2026
CIK 0002139960

Amron Holdings LLC

Relationship
Director
Address
19 CHESTERFIELD ROAD, SCARSDALE
Signature
Amron Holdings LLC, By: Arthur Amron, Manager
Signature date
16 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEPH transaction

Common Stock

Other

Transaction value
Shares
+17,749
Change %
+13%
Price
$0.000000*
Shares after
158,623
Date
14 Sep 2026
Ownership
Direct
Footnotes
F1
NEPH transaction

Common Stock

Other

Transaction value
Shares
+17,749
Change %
+13%
Price
$0.000000*
Shares after
158,623
Date
14 Sep 2026
Ownership
Direct
Footnotes
F1
NEPH transaction

Common Stock

Other

Transaction value
Shares
+2,836
Change %
Price
$0.000000*
Shares after
2,836
Date
14 Sep 2026
Ownership
See footnote
Footnotes
F1, F2, F4
NEPH transaction

Common Stock

Other

Transaction value
Shares
+2,836
Change %
Price
$0.000000*
Shares after
2,836
Date
14 Sep 2026
Ownership
See footnote
Footnotes
F1, F2, F4
NEPH transaction

Common Stock

Other

Transaction value
Shares
+22,710
Change %
+801%
Price
$3.95*
Shares after
25,546
Date
14 Sep 2026
Ownership
See footnote
Footnotes
F2, F3, F4
NEPH transaction

Common Stock

Other

Transaction value
Shares
+22,710
Change %
+801%
Price
$3.95*
Shares after
25,546
Date
14 Sep 2026
Ownership
See footnote
Footnotes
F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents an in-kind distribution from Wexford Partners 11, L.P. ("WP11"), Wexford 11 Advisors LLC ("WP Advisors") and WPIC 2 LLC ("WPIC2", and together with WP11 and WP Advisors, the "Wexford Entities") that does not involve (i) a purchase or a sale of securities or (ii) any additional consideration.

Footnote F2

Represents the common stock of the Issuer held by Amron Holdings LLC ("Amron Holdings").

Footnote F3

Represents a sale of certain shares of common stock from the Wexford Entities to Amron Holdings, the proceeds of which were distributed to certain underlying investors of the Wexford Entities. No Wexford Entities shall receive any compensation, directly or indirectly, in connection with the transaction described herein.

Footnote F4

Arthur Amron may, by reason of his status as a controlling person of Amron Holdings, be deemed to own beneficially the securities held by Amron Holdings. Mr. Amron holds the power to vote and to dispose of the securities held by Amron Holdings.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .